HIV and malaria co-infection: interactions and consequences of chemotherapy
- 1 June 2008
- journal article
- review article
- Published by Elsevier in Trends in Parasitology
- Vol. 24 (6) , 264-271
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo cityVirus Research, 2007
- Effects of Human Immunodeficiency Virus Protease Inhibitors on the Intestinal Absorption of Tenofovir Disoproxil Fumarate In VitroAntimicrobial Agents and Chemotherapy, 2007
- Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyJAMA, 2007
- Synergistic Interactions of the Antiretroviral Protease Inhibitors Saquinavir and Ritonavir with Chloroquine and Mefloquine against Plasmodium falciparum In VitroAntimicrobial Agents and Chemotherapy, 2007
- Decreasingpfmdr1Copy Number inPlasmodium falciparumMalaria Heightens Susceptibility to Mefloquine, Lumefantrine, Halofantrine, Quinine, and ArtemisininThe Journal of Infectious Diseases, 2006
- Antimalarial Effects of Human Immunodeficiency Virus Type 1 Protease Inhibitors Differ from Those of the Aspartic Protease Inhibitor PepstatinAntimicrobial Agents and Chemotherapy, 2006
- Antimalarial Activity of Human Immunodeficiency Virus Type 1 Protease InhibitorsAntimicrobial Agents and Chemotherapy, 2005
- Maternal Health and HIVReproductive Health Matters, 2005
- SaquinavirDrugs, 2003
- Pharmacokinetic Interactions of Antimalarial AgentsClinical Pharmacokinetics, 2001